Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-12-13
2000-02-15
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31195
Patent
active
060253932
ABSTRACT:
This invention relates to a method for treatment of inflammatory intestinal diseases which comprises administering bucillamine or a salt thereof and pharmaceutical acceptable carriers. Bucillamine exhibits an excellent suppressive effect on disorders of the mucous membrance and exhibits a therapeutic effect on ulcerative colitis. Bucillamine is very useful for treatment of inflammatory intestinal diseases.
REFERENCES:
patent: 4241086 (1980-12-01), Iwao et al.
patent: 4255446 (1981-03-01), Iwao et al.
patent: 4305958 (1981-12-01), Fujita et al.
patent: 4482709 (1984-11-01), Iwao et al.
The Merck Index, 11th ed., published by Merck & Co., Inc (N.J.), p. 221, cit.#1447, 1989.
Pharmacy Power-Pak, Continuing Pharmacy Education Inflammatory Bowel Disease Therapy, published by Marion Merrell Dow, Inc., pp. 14-18, 1993.
Henley III Raymond
Santen Pharmaceutical Co. Ltd.
LandOfFree
Method for treatment of inflammatory intestinal diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of inflammatory intestinal diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of inflammatory intestinal diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1906442